Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction
Condition(s):Heart Failure, Left Sided; Left Ventricular Dysfunction; Ventricular RemodelingLast Updated:May 28, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Heart Failure, Left Sided; Left Ventricular Dysfunction; Ventricular RemodelingLast Updated:May 28, 2020Completed
Condition(s):Heart FailureLast Updated:August 11, 2020Completed
Condition(s):Heart FailureLast Updated:April 23, 2019Completed
Condition(s):Acute Heart FailureLast Updated:January 20, 2021Recruiting
Condition(s):Heart Failure With Reduced Ejection Fraction (HFrEF); Dilated CardiomyopathyLast Updated:January 5, 2021Recruiting
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:September 28, 2020Recruiting
Condition(s):Heart Failure With Reduced Ejection Fraction (HF-rEF)Last Updated:January 10, 2020Available
Condition(s):Heart Failure; Chronic Heart Failure With Reduced Ejection FractionLast Updated:July 14, 2020Completed
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:December 30, 2020Recruiting
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:October 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.